Amneal Pharmaceuticals (NASDAQ:AMRX) has received FDA approval for its generic version of the GLP-1 agonist diabetes drug Byetta and resubmitted its New Drug Application for a prefilled syringe ...

A new study reveals disappointing results on the potential of GLP-1 drugs like Ozempic to treat ... and available under the brand name Byetta, or with a placebo. While it is one of the GLP-1 ...

Among people who were prescribed a GLP-1 medication for weight loss – such as semaglutide (branded as Ozempic and Wegovy), ...

Medication for weight loss is very popular ... starting with the approval of Byetta, with follow-on products continually improving on efficacy. The most recent, Ozempic and Mounjaro, offer ...

This Copenhagen-based biotech is developing a peptide analog of Amylin's Byetta (glucagon-like peptide ... so they're well-positioned if any of their drugs work.” The nearest competitor, she ...

Medication for weight loss is very popular ... starting with the approval of Byetta, with follow-on products continually improving on efficacy. The most recent, Ozempic and Mounjaro, offer ...

Two such drugs are currently approved — exenatide (Byetta; Amylin/Eli Lilly and Company) and liraglutide (Victoza; NovoNordisk) — both of which are administered by injection. This success has ...

Medication for weight loss is very popular ... starting with the approval of Byetta, with follow-on products continually improving on efficacy. The most recent, Ozempic and Mounjaro, offer significant ...